|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.35 CNY | -0.67% |
|
-6.25% | -14.81% |
| May. 22 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| May. 19 | China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug | MT |
| Market Cap | 3.47B 512M 448M 416M 383M 721M 49.39B 732M 4.96B 1.94B 24.17B 1.92B 1.88B 83.49B | P/E 2024 |
79.5x | P/E 2025 | -63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.74B 553M 484M 450M 413M 778M 53.32B 790M 5.35B 2.1B 26.09B 2.07B 2.03B 90.14B | EV / Sales 2024 |
2.95x | EV / Sales 2025 | 3.69x |
| Free-Float |
41.96% | Yield 2024 |
1.57% | Yield 2025 | - |
| 1 day | -0.67% | ||
| 1 week | -6.25% | ||
| Current month | +9.41% | ||
| 1 month | +5.83% | ||
| 3 months | -15.85% | ||
| 6 months | -23.05% | ||
| Current year | -14.81% |
| 1 week | 10 |  | 12.11 |
| 1 month | 9.02 | | 12.14 |
| Current year | 9.02 | | 18.96 |
| 1 year | 9.02 | | 18.96 |
| 3 years | 6.81 | | 19.56 |
| 5 years | 6.81 | | 22.25 |
| 10 years | 6.81 | | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 2018-10-20 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 2011-04-15 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 2018-01-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Min Chen
CHM | Chairman | 60 | 2018-10-20 |
Zhi Jun Hua
CHM | Chairman | 57 | 2011-04-15 |
Jie Liu
BRD | Director/Board Member | 50 | 2020-03-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | -6.25% | -23.22% | -23.11% | 515M | |
| -1.05% | +0.55% | +49.79% | +153.20% | 1,048B | |
| +2.00% | +3.49% | +52.22% | +49.42% | 603B | |
| -1.09% | +3.76% | +35.37% | +76.91% | 452B | |
| -0.42% | +1.65% | +30.05% | +21.05% | 327B | |
| -0.16% | +2.39% | +36.91% | +37.33% | 283B | |
| +1.68% | +2.73% | +24.14% | +17.94% | 259B | |
| -1.40% | -0.06% | -22.24% | -42.39% | 219B | |
| -0.05% | +2.16% | +19.75% | +55.49% | 198B | |
| +0.05% | -1.03% | +18.31% | +67.83% | 162B | |
| Average | -0.10% | +0.31% | +22.11% | +41.37% | 355.22B | |
| Weighted average by Cap. | -0.13% | +1.69% | +36.10% | +73.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.18B 175M 153M 142M 131M 246M 16.85B 250M 1.69B 662M 8.24B 655M 641M 28.48B | 1.18B 174M 152M 141M 130M 245M 16.76B 248M 1.68B 659M 8.2B 652M 638M 28.33B |
| Net income | 39.88M 5.89M 5.16M 4.79M 4.4M 8.3M 568M 8.42M 57.07M 22.34M 278M 22.11M 21.63M 961M | -63.47M -9.37M -8.21M -7.62M -7.01M -13.2M -904M -13.4M -90.82M -35.55M -443M -35.18M -34.43M -1.53B |
| Net Debt | 294M 43.41M 38.04M 35.31M 32.45M 61.14M 4.19B 62.04M 421M 165M 2.05B 163M 159M 7.08B | 276M 40.77M 35.72M 33.16M 30.47M 57.42M 3.93B 58.27M 395M 155M 1.93B 153M 150M 6.65B |
Employees
1,655
Sector
Pharmaceuticals
Calendar
Aug. 20
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-21 | CN¥10.35 | -0.67% | 10,823,622 |
| 26-07-21 | CN¥10.42 | -1.51% | 15,811,198 |
| 26-07-20 | CN¥10.58 | -0.66% | 18,430,537 |
| 26-07-17 | CN¥10.65 | -9.97% | 22,977,048 |
| 26-07-16 | CN¥11.83 | +0.17% | 27,719,096 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
